TLRY — Tilray Brands Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Annual income statement for Tilray Brands, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 May 31st	2022 May 31st	2023 May 31st	2024 May 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	210	513	628	627	789
Cost of Revenue
Gross Profit	24.7	123	117	147	223
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	350	645	1,239	1,997	964
Operating Profit	-140	-132	-610	-1,370	-175
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-277	-345	-441	-1,450	-249
Provision for Income Taxes
Net Income After Taxes	-271	-336	-434	-1,443	-222
Minority Interest
Net Income Before Extraordinary Items
Net Income	-271	-367	-477	-1,453	-245
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-271	-367	-477	-1,453	-245
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-2.14	-1.37	-0.459	-1.29	-0.297